PMID- 35647395
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220716
IS  - 2452-1094 (Print)
IS  - 2452-1094 (Electronic)
IS  - 2452-1094 (Linking)
VI  - 7
IP  - 3
DP  - 2022 May-Jun
TI  - Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation 
      Oncology.
PG  - 100917
LID - 10.1016/j.adro.2022.100917 [doi]
LID - 100917
AB  - PURPOSE: Radiation treatment plans undergo peer review during chart rounds, but 
      changes to treatment volumes would require replanning. Our group implemented 
      weekly head and neck cancer "volume rounds" to peer review all target volumes for 
      head and neck cancer before radiation therapy (RT) planning and chart rounds. 
      METHODS AND MATERIALS: We analyzed modifications made to planning target volumes 
      (PTVs) at volume rounds for consecutive nonproton head and neck cancer cases from 
      May 2020 to May 2021. Nine head and neck radiation oncologists participated in 
      weekly volume rounds during this time. Recommendations were categorized as no 
      changes, minor changes, major changes, additional workup (eg, biopsy or imaging), 
      and consultation or tumor board discussion needed before the start of RT. Minor 
      changes to PTVs generally did not require a second review before treatment 
      planning while major changes did. RESULTS: PTVs for 511 cases involving 432 
      patients underwent peer review and 298 (58.3%) of these cases did not require any 
      modifications before treatment planning. Minor and major changes were recommended 
      in 75 (14.7%) and 86 (16.8%) cases, respectively. Forty-five (8.8%) cases were 
      recommended to have additional workup and 23 (4.5%) required additional 
      consultation with nonradiation surgeons or medical oncologists. Of the 45 cases 
      that were recommended for additional workup, 40 underwent biopsy or imaging. 
      Positive findings on imaging or biopsy occurred in 13 patients, leading to a 
      significant change in management, including 4 patients who underwent additional 
      surgery after positive findings before the start of RT. CONCLUSIONS: Prospective 
      peer review during head and neck cancer volume rounds led to frequent minor and 
      major alterations to PTVs. Significant changes in the overall treatment plan, 
      such as additional surgery before start of RT, occurred in a minority of 
      patients.
CI  - (c) 2022 The Authors.
FAU - Hesse, Jennifer
AU  - Hesse J
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Chen, Linda
AU  - Chen L
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Yu, Yao
AU  - Yu Y
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Kang, Jung Julie
AU  - Kang JJ
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Riaz, Nadeem
AU  - Riaz N
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Tsai, C Jillian
AU  - Tsai CJ
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - McBride, Sean M
AU  - McBride SM
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Gelblum, Daphna
AU  - Gelblum D
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Zakeri, Kaveh
AU  - Zakeri K
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
FAU - Lee, Nancy Y
AU  - Lee NY
AD  - Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New 
      York, NY.
LA  - eng
GR  - P30 CA008748/CA/NCI NIH HHS/United States
PT  - Journal Article
DEP - 20220206
PL  - United States
TA  - Adv Radiat Oncol
JT  - Advances in radiation oncology
JID - 101677247
PMC - PMC9133360
EDAT- 2022/06/02 06:00
MHDA- 2022/06/02 06:01
PMCR- 2022/02/06
CRDT- 2022/06/01 11:47
PHST- 2022/01/27 00:00 [received]
PHST- 2022/01/28 00:00 [accepted]
PHST- 2022/06/01 11:47 [entrez]
PHST- 2022/06/02 06:00 [pubmed]
PHST- 2022/06/02 06:01 [medline]
PHST- 2022/02/06 00:00 [pmc-release]
AID - S2452-1094(22)00024-0 [pii]
AID - 100917 [pii]
AID - 10.1016/j.adro.2022.100917 [doi]
PST - epublish
SO  - Adv Radiat Oncol. 2022 Feb 6;7(3):100917. doi: 10.1016/j.adro.2022.100917. 
      eCollection 2022 May-Jun.